Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: Expert Opinions on HIV Cure Research
  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

Policy & Politics

House Passes Spending Bill Maintaining Funding Levels for Ryan White CARE Act, Funding Drug Trials for Medications Used by Children

September 10, 2004

The House of Representatives on Thursday approved 388-13 a health, labor and education spending bill including provisions funding clinical trials of generic drugs used by children and maintaining "flat" funding for the Ryan White CARE Act, according to an Elizabeth Glaser Pediatric AIDS Foundation release. The measure directs NIH to fund studies to prove whether certain generic drugs are safe and effective for use by children, according to the release. "There are still too many drugs used by children that have never been properly studied for pediatric use," Mark Isaac, vice president of EGPAF, said, adding, "We learned over the years that it is dangerous and sometimes tragic to assume that medications studied only in adults will work the same in children" (EGPAF release, 9/9). President Bush in 2002 signed into law the Best Pharmaceuticals for Children Act, which created an NIH research fund for pediatric studies of certain on-patent and generic drugs (Kaiser Daily HIV/AIDS Report, 1/22/03). The spending bill passed on Thursday "stresses the importance" of the research fund and directs NIH to identify drugs for pediatric study and begin clinical trials, according to the release. "We applaud the bipartisan support for the research fund at NIH, which advances our goal of ensuring that all drugs used by children are adequately studied and proven safe and effective for their use," Isaac said.

Ryan White CARE Act
In addition to the funding for the drug trials, the spending bill also included "flat" funding for the Ryan White CARE Act, according to the release (EGPAF release, 9/9). The Ryan White CARE Act funds more than 2,700 providers who serve a total of more than 500,000 people living with HIV/AIDS (Kaiser Daily HIV/AIDS Report, 8/24). "Considering the devastating impact that HIV continues to have on young people and their families, now is not the time to shortchange critical domestic HIV/AIDS programs, including Ryan White," Isaac said, adding, "We call on the Senate to do a better job of protecting the health of children and adults with HIV/AIDS" (EGPAF release, 9/9).

Back to other news for September 10, 2004


Reprinted with permission from kaisernetwork.org. You can view the entire Kaiser Daily HIV/AIDS Report, search the archives, or sign up for email delivery at www.kaisernetwork.org/dailyreports/hiv. The Kaiser Daily HIV/AIDS Report is published for kaisernetwork.org, a free service of the Kaiser Family Foundation, by The Advisory Board Company. © 2004 by The Advisory Board Company and Kaiser Family Foundation. All rights reserved.



  
  • Email Email
  • Printable Single-Page Print-Friendly
  • Glossary Glossary

This article was provided by Henry J. Kaiser Family Foundation. It is a part of the publication Kaiser Daily HIV/AIDS Report. Visit the Kaiser Family Foundation's website to find out more about their activities, publications and services.
 
See Also
More HIV News

Tools
 

Advertisement